Finance

Beta
Lists
HUM:NYSE
Humana Inc
$361.64
0.00%
(0.00) 1D
Jun 24, 4:03:22 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HUM...
Mkt. cap
43.42B
Avg. vol.
1.56M
Volume
175.00
Dividend
0.98%
Quarterly dividend
$0.88
Ex-dividend date
Jun 26, 2026
P/E ratio
38.70
52-wk high
$380.86
52-wk low
$163.11
EPS
$9.34
Beta
0.76
Shares outstanding
120.06M
No. of employees
67K
Mkt. cap
43.42B
Avg. vol.
1.56M
Volume
175.00
Dividend
0.98%
Quarterly dividend
$0.88
Ex-dividend date
Jun 26, 2026
P/E ratio
38.70
52-wk high
$380.86
52-wk low
$163.11
EPS
$9.34
Beta
0.76
Shares outstanding
120.06M
No. of employees
67K
News stories
From sources across the web
Profile
Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list, which made it the highest ranked company based in Kentucky. It is the fourth largest health insurance provider in the U.S. Wikipedia
About Humana Inc
CEOJim Rechtin
Employees67.1K
Founded1961
HeadquartersLouisville, Kentucky, United States
SectorHealth care provider
Websitehumana.com
Analyst Ratings
Based on 19 analysts giving stock ratings to HUM in the past 3 months
Hold
Buy
6
Hold
11
Sell
2
12 month forecast
Based on 19 Wall Street analysts offering 12 month price targets for HUM in the last 3 months.
Highest
Current $361.64
$441.00 (+21.94%)
Average
$294.56 (-18.55%)
Lowest
$195.00 (-46.08%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Kevin Fischbeck
Bank of America Securities
Hold
Reiterated
$380.00
+5.1%
06/24/2026
Lance Wilkes
Bernstein
Buy
Maintained
$425.00
+17.5%
06/09/2026
Lisa Gill
J.P. Morgan
Hold
Maintained
$316.00
-12.6%
06/08/2026
Ann Hynes
Mizuho Securities
Buy
Maintained
$390.00
+7.8%
06/08/2026
Stephen Baxter
Wells Fargo
Hold
Maintained
$227.00
-37.2%
06/04/2026
Erin Wright
Morgan Stanley
Sell
Reiterated
$249.00
-31.1%
06/04/2026
David S Macdonald
Truist Financial
Hold
Reiterated
$320.00
-11.5%
06/01/2026
Courtney Breen
Bernstein
Buy
Maintained
$288.00
-20.4%
05/27/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$344.00
-4.9%
05/26/2026
A.J. Rice
UBS
Hold
Maintained
$320.00
-11.5%
05/22/2026
George Hill
Deutsche Bank
Buy
Upgraded
$441.00
+21.9%
05/20/2026
Jessica Tassan
Piper Sandler
Hold
Maintained
$254.00
-29.8%
05/13/2026
John Ransom
Raymond James
Buy
Maintained
$260.00
-28.1%
05/01/2026
Ryan Langston
TD Cowen
Hold
Reiterated
$211.00
-41.7%
05/01/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$260.00
-28.1%
04/30/2026
Scott Fidel
Goldman Sachs
Sell
Maintained
$195.00
-46.1%
04/30/2026
Ben Hendrix
RBC Capital
Hold
Maintained
$246.00
-32%
04/29/2026
Jason Cassorla
Guggenheim
Buy
Maintained
$269.00
-25.6%
04/29/2026
Kevin Caliendo
UBS
Hold
Maintained
$262.00
-27.6%
04/30/2026
Matthew Gillmor CFA
KeyBanc
Hold
Maintained
-
-
04/30/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$195.00
-46.1%
04/29/2026
David Windley
Jefferies
Buy
Maintained
$235.00
-35%
02/27/2026
Sarah James
Cantor Fitzgerald
Hold
Maintained
$201.00
-44.4%
02/11/2026
Last report
Apr 29, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$10.31 / $10.16
+1.52%beat
Revenue / Est. (USD)
39.65B / 39.39B
+0.66%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
32.39B
32.65B
32.52B
39.65B
Cost of goods sold
27.56B
27.99B
28.72B
33.71B
Cost of revenue
27.56B
27.99B
28.72B
33.71B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.49B
3.82B
4.21B
3.93B
Operating expense
3.66B
3.99B
4.38B
4.09B
Total operating expenses
31.23B
31.98B
33.10B
37.80B
Operating income
1.16B
667.00M
-583.00M
1.85B
Other non operating income
-200.00M
-35.00M
-53.00M
34.00M
EBT including unusual items
722.00M
108.00M
-1.02B
1.58B
EBT excluding unusual items
783.00M
438.00M
-796.00M
1.68B
Income tax expense
179.00M
-86.00M
-249.00M
395.00M
Effective tax rate
24.79%
-79.63%
24.29%
25.02%
Other operating expenses
-
-
-
-
Net income
545.00M
195.00M
-796.00M
1.19B
Net profit margin
1.68%
0.60%
-2.45%
2.99%
Earnings per share
6.27
3.24
-3.96
10.31
Interest and investment income
-
-
-
-
Interest expense
-157.00M
-168.00M
-146.00M
-193.00M
Net interest expenses
-157.00M
-168.00M
-146.00M
-193.00M
Depreciation and amortization charges
178.00M
173.00M
164.00M
163.00M
EBITDA
1.37B
871.00M
-389.00M
2.05B
Gain or loss from assets sale
-
63.00M
4.00M
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer